GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc (GSK) was advised on 1 October 2014, that on 30 September 2014 the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.22 per Ordinary Share, and notional ADSs at a price of $46.31 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2014 to 30 September 2014:
Non Executive Director |
Ordinary Shares |
American Depositary Shares (ADSs) |
Sir Christopher Gent |
4,395.218 |
|
Professor Sir Roy Anderson |
505.450 |
|
Dr Stephanie Burns |
|
633.729 |
Stacey Cartwright |
373.594 |
|
Lynn Elsenhans |
|
1,140.713 |
Judy Lewent |
|
491.686 |
Sir Deryck Maughan |
|
1,529.691 |
Dr Daniel Podolsky |
|
1,147.268 |
Tom de Swaan |
461.498 |
|
Jing Ulrich |
|
316.865 |
Hans Wijers |
373.594 |
|
V A Whyte
Company Secretary
1 October 2014